nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—CYP2C18—Xenobiotics—CYP2A7—nicotine dependence	0.0351	0.0583	CbGpPWpGaD
Diphenhydramine—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0279	0.0462	CbGpPWpGaD
Diphenhydramine—Chest discomfort—Varenicline—nicotine dependence	0.0263	0.0795	CcSEcCtD
Diphenhydramine—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.0217	0.0361	CbGpPWpGaD
Diphenhydramine—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0211	0.0349	CbGpPWpGaD
Diphenhydramine—Euphoric mood—Varenicline—nicotine dependence	0.02	0.0605	CcSEcCtD
Diphenhydramine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0194	0.0321	CbGpPWpGaD
Diphenhydramine—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0192	0.0318	CbGpPWpGaD
Diphenhydramine—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.0173	0.0286	CbGpPWpGaD
Diphenhydramine—Irritability—Varenicline—nicotine dependence	0.0161	0.0488	CcSEcCtD
Diphenhydramine—Urinary retention—Varenicline—nicotine dependence	0.0161	0.0486	CcSEcCtD
Diphenhydramine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.0151	0.0251	CbGpPWpGaD
Diphenhydramine—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0146	0.0242	CbGpPWpGaD
Diphenhydramine—CYP2C18—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0144	0.0239	CbGpPWpGaD
Diphenhydramine—Pollakiuria—Varenicline—nicotine dependence	0.0135	0.0408	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Varenicline—nicotine dependence	0.0133	0.0403	CcSEcCtD
Diphenhydramine—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.0131	0.0216	CbGpPWpGaD
Diphenhydramine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.012	0.0199	CbGpPWpGaD
Diphenhydramine—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.0119	0.0197	CbGpPWpGaD
Diphenhydramine—CYP2C18—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0118	0.0196	CbGpPWpGaD
Diphenhydramine—Levomethadyl Acetate—CHRNB4—nicotine dependence	0.0115	0.173	CrCbGaD
Diphenhydramine—Tinnitus—Varenicline—nicotine dependence	0.0109	0.033	CcSEcCtD
Diphenhydramine—Chills—Varenicline—nicotine dependence	0.0105	0.0317	CcSEcCtD
Diphenhydramine—Methadyl Acetate—OPRM1—nicotine dependence	0.0104	0.157	CrCbGaD
Diphenhydramine—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.0102	0.0169	CbGpPWpGaD
Diphenhydramine—Vision blurred—Varenicline—nicotine dependence	0.00959	0.029	CcSEcCtD
Diphenhydramine—Tremor—Varenicline—nicotine dependence	0.00953	0.0288	CcSEcCtD
Diphenhydramine—Methadone—CHRNA10—nicotine dependence	0.00938	0.141	CrCbGaD
Diphenhydramine—Agitation—Varenicline—nicotine dependence	0.00935	0.0283	CcSEcCtD
Diphenhydramine—Vertigo—Varenicline—nicotine dependence	0.00914	0.0276	CcSEcCtD
Diphenhydramine—Palpitations—Varenicline—nicotine dependence	0.00899	0.0272	CcSEcCtD
Diphenhydramine—Convulsion—Varenicline—nicotine dependence	0.00881	0.0267	CcSEcCtD
Diphenhydramine—Dry mouth—Varenicline—nicotine dependence	0.00847	0.0256	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Varenicline—nicotine dependence	0.00813	0.0246	CcSEcCtD
Diphenhydramine—Tachycardia—Varenicline—nicotine dependence	0.0081	0.0245	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Varenicline—nicotine dependence	0.00802	0.0243	CcSEcCtD
Diphenhydramine—Levomethadyl Acetate—CHRNA3—nicotine dependence	0.00797	0.12	CrCbGaD
Diphenhydramine—Anorexia—Varenicline—nicotine dependence	0.00791	0.0239	CcSEcCtD
Diphenhydramine—Hypotension—Varenicline—nicotine dependence	0.00776	0.0235	CcSEcCtD
Diphenhydramine—PTGS1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00762	0.0126	CbGpPWpGaD
Diphenhydramine—Insomnia—Varenicline—nicotine dependence	0.00751	0.0227	CcSEcCtD
Diphenhydramine—Somnolence—Varenicline—nicotine dependence	0.00738	0.0223	CcSEcCtD
Diphenhydramine—Dyspepsia—Varenicline—nicotine dependence	0.00731	0.0221	CcSEcCtD
Diphenhydramine—Decreased appetite—Varenicline—nicotine dependence	0.00722	0.0218	CcSEcCtD
Diphenhydramine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00717	0.0119	CbGpPWpGaD
Diphenhydramine—Fatigue—Varenicline—nicotine dependence	0.00716	0.0216	CcSEcCtD
Diphenhydramine—Constipation—Varenicline—nicotine dependence	0.0071	0.0215	CcSEcCtD
Diphenhydramine—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00708	0.0117	CbGpPWpGaD
Diphenhydramine—Feeling abnormal—Varenicline—nicotine dependence	0.00684	0.0207	CcSEcCtD
Diphenhydramine—CYP2C18—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00667	0.0111	CbGpPWpGaD
Diphenhydramine—Urticaria—Varenicline—nicotine dependence	0.00659	0.0199	CcSEcCtD
Diphenhydramine—HRH1—Monoamine GPCRs—DRD2—nicotine dependence	0.0064	0.0106	CbGpPWpGaD
Diphenhydramine—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.0063	0.0104	CbGpPWpGaD
Diphenhydramine—CYP2C18—Biological oxidations—CYP2A7—nicotine dependence	0.00628	0.0104	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0062	0.0103	CbGpPWpGaD
Diphenhydramine—Asthenia—Varenicline—nicotine dependence	0.00596	0.018	CcSEcCtD
Diphenhydramine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00582	0.00964	CbGpPWpGaD
Diphenhydramine—Diarrhoea—Varenicline—nicotine dependence	0.00568	0.0172	CcSEcCtD
Diphenhydramine—Dizziness—Varenicline—nicotine dependence	0.00549	0.0166	CcSEcCtD
Diphenhydramine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00542	0.00899	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00539	0.00894	CbGpPWpGaD
Diphenhydramine—HRH1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00538	0.00893	CbGpPWpGaD
Diphenhydramine—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00535	0.00887	CbGpPWpGaD
Diphenhydramine—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0053	0.00878	CbGpPWpGaD
Diphenhydramine—Vomiting—Varenicline—nicotine dependence	0.00528	0.016	CcSEcCtD
Diphenhydramine—Rash—Varenicline—nicotine dependence	0.00523	0.0158	CcSEcCtD
Diphenhydramine—Dermatitis—Varenicline—nicotine dependence	0.00523	0.0158	CcSEcCtD
Diphenhydramine—Headache—Varenicline—nicotine dependence	0.0052	0.0157	CcSEcCtD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00511	0.00848	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00503	0.00834	CbGpPWpGaD
Diphenhydramine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00499	0.00827	CbGpPWpGaD
Diphenhydramine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00494	0.0082	CbGpPWpGaD
Diphenhydramine—Nausea—Varenicline—nicotine dependence	0.00493	0.0149	CcSEcCtD
Diphenhydramine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00492	0.00816	CbGpPWpGaD
Diphenhydramine—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00488	0.00809	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00486	0.00805	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00477	0.0079	CbGpPWpGaD
Diphenhydramine—Levomethadyl Acetate—OPRM1—nicotine dependence	0.00453	0.0682	CrCbGaD
Diphenhydramine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00439	0.00729	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0043	0.00713	CbGpPWpGaD
Diphenhydramine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00422	0.007	CbGpPWpGaD
Diphenhydramine—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00417	0.00691	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—CHRNB3—nicotine dependence	0.00413	0.00685	CbGpPWpGaD
Diphenhydramine—PTGS1—Biological oxidations—CYP2A7—nicotine dependence	0.00405	0.00671	CbGpPWpGaD
Diphenhydramine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00404	0.0067	CbGpPWpGaD
Diphenhydramine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00401	0.00664	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—CHRNA6—nicotine dependence	0.00392	0.0065	CbGpPWpGaD
Diphenhydramine—Dextropropoxyphene—OPRM1—nicotine dependence	0.00392	0.0589	CrCbGaD
Diphenhydramine—Fentanyl—OPRM1—nicotine dependence	0.00387	0.0583	CrCbGaD
Diphenhydramine—SLC22A1—Neuronal System—CHRNB3—nicotine dependence	0.00385	0.00639	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.0037	0.00613	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00369	0.00611	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—CHRNA6—nicotine dependence	0.00365	0.00606	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00354	0.00588	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00345	0.00571	CbGpPWpGaD
Diphenhydramine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00342	0.00568	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.0033	0.00548	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00329	0.00546	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00328	0.00543	CbGpPWpGaD
Diphenhydramine—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.00309	0.00512	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00307	0.00509	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00305	0.00505	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00302	0.00501	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.0029	0.00481	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—GABRA4—nicotine dependence	0.00283	0.0047	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—CHRNB4—nicotine dependence	0.00272	0.0045	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00269	0.00445	CbGpPWpGaD
Diphenhydramine—Methadone—OPRM1—nicotine dependence	0.00266	0.04	CrCbGaD
Diphenhydramine—HRH1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00265	0.00439	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—GABRA4—nicotine dependence	0.00264	0.00438	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.0026	0.00432	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—CHRNB4—nicotine dependence	0.00253	0.0042	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—CHRNA5—nicotine dependence	0.00252	0.00419	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.0025	0.00415	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00248	0.00411	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00246	0.00408	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00242	0.00401	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00236	0.00392	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—CHRNA5—nicotine dependence	0.00235	0.0039	CbGpPWpGaD
Diphenhydramine—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.00233	0.00387	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0023	0.00382	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00228	0.00378	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00226	0.00374	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00223	0.0037	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.0022	0.00365	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00215	0.00356	CbGpPWpGaD
Diphenhydramine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00215	0.00356	CbGpPWpGaD
Diphenhydramine—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.00213	0.00353	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00212	0.00351	CbGpPWpGaD
Diphenhydramine—Cinnarizine—DRD2—nicotine dependence	0.0021	0.0316	CrCbGaD
Diphenhydramine—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0021	0.00348	CbGpPWpGaD
Diphenhydramine—Amitriptyline—OPRM1—nicotine dependence	0.00207	0.0311	CrCbGaD
Diphenhydramine—SLC22A2—Neuronal System—CHRNA3—nicotine dependence	0.00206	0.00341	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.002	0.00332	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00193	0.0032	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—CHRNA3—nicotine dependence	0.00192	0.00318	CbGpPWpGaD
Diphenhydramine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.00182	0.00302	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00181	0.00301	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—CHRNB2—nicotine dependence	0.00181	0.003	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00179	0.00297	CbGpPWpGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00171	0.00283	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—CHRNB2—nicotine dependence	0.00169	0.0028	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00168	0.00279	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—CHRNA4—nicotine dependence	0.00165	0.00273	CbGpPWpGaD
Diphenhydramine—Trimipramine—DRD2—nicotine dependence	0.00154	0.0231	CrCbGaD
Diphenhydramine—SLC22A1—Neuronal System—CHRNA4—nicotine dependence	0.00153	0.00254	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00152	0.00253	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00149	0.00248	CbGpPWpGaD
Diphenhydramine—Promethazine—DRD2—nicotine dependence	0.00148	0.0222	CrCbGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00147	0.00244	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00146	0.00243	CbGpPWpGaD
Diphenhydramine—Doxepin—DRD2—nicotine dependence	0.00146	0.022	CrCbGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00144	0.00239	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00142	0.00235	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00136	0.00225	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00134	0.00222	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.00131	0.00217	CbGpPWpGaD
Diphenhydramine—Promazine—DRD2—nicotine dependence	0.0013	0.0196	CrCbGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00124	0.00205	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00122	0.00202	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.00117	0.00195	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.00115	0.00191	CbGpPWpGaD
Diphenhydramine—Imipramine—DRD2—nicotine dependence	0.00114	0.0171	CrCbGaD
Diphenhydramine—Amitriptyline—DRD2—nicotine dependence	0.00113	0.017	CrCbGaD
Diphenhydramine—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.00112	0.00185	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.0011	0.00182	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—CYP2A7—nicotine dependence	0.00107	0.00178	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—FGD1—nicotine dependence	0.00107	0.00177	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00106	0.00176	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.00105	0.00174	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00104	0.00173	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—DRD2—nicotine dependence	0.000806	0.00134	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	0.000802	0.00133	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000793	0.00132	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000789	0.00131	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CYP2A7—nicotine dependence	0.000713	0.00118	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CYP2A7—nicotine dependence	0.000692	0.00115	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP2A7—nicotine dependence	0.000665	0.0011	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	0.00063	0.00105	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGD1—nicotine dependence	0.000629	0.00104	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.00062	0.00103	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.000619	0.00103	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	0.000572	0.000949	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.000563	0.000934	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	0.000556	0.000922	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000547	0.000907	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000528	0.000876	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	0.000456	0.000756	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.000448	0.000743	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—DRD2—nicotine dependence	0.000414	0.000686	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000407	0.000675	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000399	0.000662	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—WASF2—nicotine dependence	0.000392	0.000649	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000385	0.000639	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—WASF1—nicotine dependence	0.000375	0.000623	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000369	0.000613	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000367	0.000609	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000364	0.000604	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—OPRM1—nicotine dependence	0.000338	0.000561	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000333	0.000552	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000311	0.000516	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—DRD2—nicotine dependence	0.000244	0.000405	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.00024	0.000399	CbGpPWpGaD
